Makhloufi Zoulikha

机构：China Pharmaceutical University · ORCID：0000-0002-1480-550X

发表论文 10 篇 · 总被引 1184 次 · h-index 9

代表论文

• Multifunctional nanoparticle-mediated combining therapy for human diseases (2024 · Signal Transduction and Targeted Therapy · 被引 501)
• Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome (2021 · Acta Pharmaceutica Sinica B · 被引 274)
• The effects of protein corona on in vivo fate of nanocarriers (2022 · Advanced Drug Delivery Reviews · 被引 246)
• Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes (2022 · Chinese Chemical Letters · 被引 44)
• COVID-19 inflammation and implications in drug delivery (2022 · Journal of Controlled Release · 被引 29)
• Metal phenolic network-stabilized nanocrystals of andrographolide to alleviate macrophage-mediated inflammation in-vitro (2022 · Chinese Chemical Letters · 被引 26)